Fleming, B. D., Urban, D. J., Hall, M., Longerich, T., Greten, T., Pastan, I., & Ho, M. (2020). The engineered anti-GPC3 immunotoxin, HN3-ABD-T20, produces regression in mouse liver cancer xenografts via prolonged serum retention. Hepatology.
Chicago Stili AlıntıFleming, Bryan D., Daniel J. Urban, Matthew Hall, Thomas Longerich, Tim Greten, Ira Pastan, ve Mitchell Ho. "The Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Via Prolonged Serum Retention." Hepatology 2020.
MLA AlıntıFleming, Bryan D., et al. "The Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Via Prolonged Serum Retention." Hepatology 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..